ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 568 | +7.8% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 527 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 527 | +584.4% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 77 | -99.0% | 0.00% | – |
| Q1 2016 | $38,000 | +18.8% | 7,973 | 0.0% | 0.00% | – |
| Q4 2015 | $32,000 | +68.4% | 7,973 | +58.2% | 0.00% | – |
| Q3 2015 | $19,000 | -17.4% | 5,041 | 0.0% | 0.00% | – |
| Q2 2015 | $23,000 | -42.5% | 5,041 | -16.6% | 0.00% | – |
| Q1 2015 | $40,000 | – | 6,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $17,019,000 | 2.88% |
| Northeast Financial Consultants Inc | 732,265 | $3,368,000 | 1.50% |
| Family Management Corp | 12,008 | $55,000 | 0.04% |
| Acrospire Investment Management LLC | 6,101 | $28,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $681,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,901,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 48,790 | $224,000 | 0.01% |
| Parallel Advisors, LLC | 3,538 | $16,000 | 0.00% |
| Squarepoint Ops LLC | 15,690 | $72,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $69,000 | 0.00% |